Invasive pulmonary aspergillosis/pseudomonas

BMJ Case Rep. 2021 Jul 13;14(7):e236887. doi: 10.1136/bcr-2020-236887.

Abstract

A 47-year-old Caucasian man on long-standing antifungal therapy for chronic necrotising aspergillosis and a history of recurrent pseudomonas pneumonias presented to the outpatient pulmonary clinic with dyspnoea and chest discomfort for 3 days. A CT angiography of the chest demonstrated angioinvasion from the previously noted left upper lobe cavitary lesion into the left main pulmonary artery, along with new consolidating lesions. Due to the high risk for massive haemoptysis, he was evaluated by thoracic surgery and underwent a successful left pneumonectomy. As invasive pulmonary aspergillosis is associated with high mortality, surgical intervention should always be considered, especially in those who develop extensive disease, despite being on aggressive antifungal therapy. Though minimally described in literature, invasive pulmonary pseudomonas also carries a high mortality risk. In our patient, cultures from the resected lung only demonstrated Pseudomonas aeruginosa.

Keywords: TB and other respiratory infections; pneumonia (infectious disease).

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use
  • Hemoptysis
  • Humans
  • Invasive Pulmonary Aspergillosis* / diagnosis
  • Invasive Pulmonary Aspergillosis* / drug therapy
  • Male
  • Middle Aged
  • Pseudomonas
  • Pulmonary Aspergillosis* / diagnostic imaging
  • Pulmonary Aspergillosis* / drug therapy

Substances

  • Antifungal Agents